Patents by Inventor Steven A. Dunham

Steven A. Dunham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20250206831
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: August 7, 2024
    Publication date: June 26, 2025
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20250206832
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: August 7, 2024
    Publication date: June 26, 2025
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • ANTI-NGF ANTIBODIES AND METHODS OF TREATING PAIN THEREOF
    Publication number: 20250154271
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: June 12, 2024
    Publication date: May 15, 2025
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • CANINE ANTI-NGF ANTIBODIES AND METHODS OF TREATING PAIN THEREOF
    Publication number: 20250115672
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: June 13, 2024
    Publication date: April 10, 2025
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Humanized anti-NGF antibodies and methods of treating pain thereof
    Patent number: 12084507
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment of NGF related disorders, particularly in for the management of pain.
    Type: Grant
    Filed: March 10, 2021
    Date of Patent: September 10, 2024
    Assignee: Zoetis Services LLC
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Methods of treating a canine and inhibiting NGF activity through use of anti-NGF antibodies
    Patent number: 12084506
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment of NGF related disorders, particularly in for the management of pain.
    Type: Grant
    Filed: March 3, 2021
    Date of Patent: September 10, 2024
    Assignee: Zoetis Services LLC
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Canine anti-NGF antibodies and methods of treating pain thereof
    Patent number: 12049508
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment of NGF related disorders, particularly in for the management of pain.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: July 30, 2024
    Assignee: Zoetis Services LLC
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Felinized anti-NGF antibodies and methods of treating pain
    Patent number: 12049507
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment of NGF related disorders, particularly in for the management of pain.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: July 30, 2024
    Assignee: Zoetis Services LLC
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Nucleic acids encoding a canine antibody which binds nerve growth factor and vectors and host cells thereof
    Patent number: 12049509
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment of NGF related disorders, particularly in for the management of pain.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: July 30, 2024
    Assignee: Zoetis Services LLC
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210253722
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 12, 2021
    Publication date: August 19, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210221899
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 5, 2021
    Publication date: July 22, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210221898
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 5, 2021
    Publication date: July 22, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210214449
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 3, 2021
    Publication date: July 15, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210214451
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 15, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210214450
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 15, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210198373
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 10, 2021
    Publication date: July 1, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210188988
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 9, 2021
    Publication date: June 24, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF antibodies and methods thereof
    Patent number: 10982002
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: April 20, 2021
    Assignee: Zoetis Services LLC
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20190276548
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: January 18, 2019
    Publication date: September 12, 2019
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Caninized anti-NGF antibodies and methods thereof
    Patent number: 9617334
    Abstract: The present disclosure encompasses novel caninized anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotides of the invention for the treatment and/or prevention of NGF related disorders, particularly for the management of canine pain.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: April 11, 2017
    Assignee: Zoetis Services LLC
    Inventors: Lisa Marie Bergeron, Graeme Bainbridge, Steven A. Dunham, Minghua Dai